GT Biopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
GT Biopharma, Inc. has filed 868 SEC EDGAR filings since 12 May 1995

SEC filing history

Showing 76-100 of 509 matching filings.

Per page
25
Current page
4
10-Q File 001-40023

10-Q filing

Filing date
14 Nov 2024
Reporting date
30 Sep 2024
Next action
Verify source filing
4

4 filing

Filing date
21 Oct 2024
Reporting date
17 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-32837

SCHEDULE 13G/A filing

Filing date
17 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-40023

10-Q filing

Filing date
14 Aug 2024
Reporting date
30 Jun 2024
Next action
Verify source filing
424B3 File 333-280326

424B3 filing

Filing date
02 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-280326

EFFECT filing

Filing date
28 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
27 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-280326

S-1/A filing

Filing date
27 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-280326

UPLOAD filing

Filing date
24 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-280326

S-1 filing

Filing date
20 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-40023

DEFA14A filing

Filing date
17 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
13 Jun 2024
Reporting date
03 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-32837

AMENDMENT NO. 17 TO SCHEDULE 13G

Filing date
23 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-267870

424B5 filing

Filing date
23 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-40023

10-Q filing

Filing date
15 May 2024
Reporting date
31 Mar 2024
Next action
Verify source filing
ARS File 001-40023

ARS filing

Filing date
29 Apr 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-40023

DEFA14A filing

Filing date
29 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-40023

DEF 14A filing

Filing date
29 Apr 2024
Reporting date
29 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .